Program times refer to Central European Time (CET)

Chairperson E. Zucca

L. Mazzucchelli Differences and similarities of updated lymphoma classifications 10.30-11.15
F. Bertoni The emerging molecular taxonomy of lymphomas 11.15-11.45
A. Tzankov The immune-microenvironment of lymphomas 11.45-12.15
L. Ceriani The current role of volumetric PET parameters in the management of lymphomas 12.15-12.45

12.45-13.45 Lunch

Chairperson F. Cavalli

M.C. Pirosa
A. Condoluci
L. Ceriani
L. Mazzucchelli
Tumor board: Difficult cases 13.45-15.00
L. Pasqualucci Key note lecture – The germinal center role in lymphoma development 15.00-16.00

16.00-16.15 Break

P. Johnson What’s new in Hodgkin Lymphoma? 16.15-17.00

17.00-18.00 Discussion of cases of participants

Chairperson S. Luminari

D. Rossi What’s new in chronic lymphocytic leukemia 8.30-9.15
M. Pirosa What’s new in Waldenström macroglobulinemia 9.15-9.30
F. Cavalli What’s new in follicular lymphomas? 9.30-10.00
A. Stathis What’s new in mantle-cell lymphomas? 10.00-10.30

10.30-11.00 Break

S. Luminari What’s new in high-grade lymphoma and Burkitt lymphoma 11.00-11.20
P. Johnson What’s new in DLBCL 11.20-11.40
S. Luminari What’s new in peripheral T-cell lymphomas 11.40-12.00

12.00-13.30 Lunch

Chairperson A. Stathis

Special Session on Extranodal Lymphoma
D. Rossi What’s new in marginal zone lymphoma 13.30-14.15
E. Zucca What’s new in primary mediastinal B-cell lymphoma 14.15-15.00
A. Ferreri What’s new in CNS primary and secondary 15.00-15.45
H. Beltraminelli What’s new in cutaneous B- and T-cell lymphoma 15.45-16.15

16.15-16.45 Break

16.45-17.45 Discussion of cases of participants

Chairperson F. Cavalli

9.00-9.45 Discussion of cases of participants

Chairperson F. Cavalli

F. Simonetta CAR-T cell 9.45-10.05
A. Condoluci Amyloidosis 10.05-10.30
E. Lerch Myeloma 10.30-11.00
A. Stathis Other immunotherapy and targeted regimens 11.00-11.30

11.30-11.45 Concluding remarks & End of the meeting by F. Cavalli